Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020.
- DOI
- 10.1016/j.diagmicrobio.2022.115713
- Published
- 2022 Jul
- Container
- Diagnostic microbiology and infectious disease
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.diagmicrobio.2022.115713,
title = {Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020.},
author = {Duncan LR and Hamed KA and Smart JI and Pfaller MA and Flamm RK and Mendes RE},
year = {2022},
journal = {Diagnostic microbiology and infectious disease},
doi = {10.1016/j.diagmicrobio.2022.115713},
url = {https://doi.org/10.1016/j.diagmicrobio.2022.115713}
}RIS
TY - JOUR TI - Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020. AU - Duncan LR AU - Hamed KA AU - Smart JI AU - Pfaller MA AU - Flamm RK AU - Mendes RE PY - 2022 JO - Diagnostic microbiology and infectious disease DO - 10.1016/j.diagmicrobio.2022.115713 UR - https://doi.org/10.1016/j.diagmicrobio.2022.115713 ER -
APA
LR, D., KA, H., JI, S., MA, P., RK, F., & RE, M. (2022). Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020.. Diagnostic microbiology and infectious disease. https://doi.org/10.1016/j.diagmicrobio.2022.115713
Source records
- pubmed · retrieved 2026-09-27T10:28:17.091Z